Osiris Therapeutics, Inc. announced that it has achieved $2 million in milestone payments from the Juvenile Diabetes Research Foundation for progress made on a Phase II clinical trial evaluating Prochymal, a …
General Health
Health Care
Nutrition
Personal Care
Sex and Sensuality
Bestsellers